Healthcare Artificial Intelligence (AI) Market - Global Outlook & Forecast 2021-2026

Lowest Prices Guaranteed	Length	Publisher	Published Date	SKU
from $3,750	377 Pages	Arizton Advisory and Intelligence	December, 2021	ARZ16847753

Lowest Prices Guaranteed
Price	from $3,750
Length	377 Pages
Publisher	Arizton Advisory and Intelligence
Published Date	December, 2021
SKU	ARZ16847753

Healthcare Artificial Intelligence (AI) Market - Global Outlook & Forecast 2021-2026

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Healthcare Artificial Intelligence (AI) Market Report

The healthcare artificial intelligence market is expected to reach USD 44.5 billion by 2026, growing at a CAGR of 46.21%.

Several pharmaceutical companies are implementing innovative technologies to boost their growth in the global healthcare industry. Collaboration of GSK with Exscientia identified a small compound for targeted therapeutics and its characteristics towards the specific target using the AI platform. AI is becoming an incredible platform in the pharmaceutical industry. For instance, Novartis announced Microsoft as a strategic partner in AI and data science to set up an AI innovation lab. Since the last year, over 50+ companies have got machine learning and AI algorithms approvals. During the COVID-19 pandemic, AI played a significant role in the healthcare industry. An analytics study by Accenture combined with clinical applications demonstrated the potential of AI to reduce approximately USD 150 billion per annum by 2026 in the US healthcare system.

The following factors are likely to contribute to the growth of the healthcare artificial intelligence market during the forecast period:

Increase in patient volume & complexities associated with data fueling demand for AI.
The shrinking operational workforce in healthcare facilities propelling the need for AI.
Technological advancement & innovations in AI influencing end-users in the market.
Rising Investment in advanced drug discovery & development process augmenting the adoption of AI.

KEY HIGHLIGHTS

The healthcare providers segment accounted for the largest market share with around 48% compared to others in 2020.
According to the research, Arizton estimated that APAC would witness the highest growth in the healthcare artificial intelligence (AI) market during the forecast period.

The study considers a detailed scenario of the present healthcare artificial intelligence market and its market dynamics for the period 2021−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET SEGMENTATION

This research report includes a detailed segmentation by

Category
Application
Technology
End-user
Geography

HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET SEGMENTS

The software industry provides numerous services to the healthcare industry. With the advent of medical software, human errors are minimized in the global medical market. Using advanced software in healthcare enables the clinical experts to expertise their practices. Software providers are gaining huge opportunities in the healthcare artificial intelligence (AI) market. Software development companies are constantly striving to improve the industry and bring innovations.

Market Segmentation by Application

Hospital Workflow Management
Medical Imaging and Diagnosis
Drug Discovery and Precision Medicine
Patient Management

Market Segmentation by Technology

Machine Learning
Querying Method
Natural Language Processing
Others

Market Segmentation by End-users

Healthcare Providers
Pharma-biotech and medical devices companies
Payers
Others

GEOGRAPHICAL ANALYSIS

US is the major revenue generator of the healthcare artificial intelligence (AI) market across the North American region. In North America, the potential increase in AI GDP is compounded by tremendous opportunities to adopt more productive technologies.

Market Segmentation by Geography

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Nordic Countries
APAC
China
India
Japan, Australia
South Korea
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Turkey
Saudi Arabia
South Africa
UAE

VENDOR ANALYSIS

Giant players are focusing on pursuing organic growth strategies to enhance their product portfolio in the healthcare artificial intelligence (AI) market. Several initiatives by the players will complement growth strategies, which are gaining traction among end-users in the market. Rising growth of startups collaborating with key vendors in promoting their artificial intelligence in healthcare applications creating heavy competition in the market.

Prominent Vendors

Google
IBM (International Business Machines)
Intel Corporation
Medtronic
Microsoft Corporation
Nvidia Corporation
Siemens Healthineers

Other Prominent Vendors

Arterys
Caption Health
Enlitic
Catalia Health
General Vision
Philips
Stryker
Shimadzu Recursion Pharmaceuticals
GE Healthcare
Remedy Medical
Subtle Medical
Netbase Quid
Biosymetrics
Sensely
InformAI
Bioclinica
Owkin
Binah.AI
Oncora Medical
Qure.AI Technologies
Lunit
Caresyntax
Anju software
Imagia Cybernetics
Deep Genomics
Welltok Inc.
MDLive
MaxQ AI
Qventus
Workfusion

KEY QUESTIONS ANSWERED:

1. How big is the healthcare artificial intelligence (AI) market?

2. Which region has the highest share in the healthcare artificial intelligence market?

3. Who are the key players in the healthcare AI market?

4. What are the latest market trends in the healthcare artificial intelligence market?

5. What is the use of AI in the healthcare market?

1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage: 4.1 Market Definition; 4.01.01 Inclusions; 4.01.02 Exclusions; 4.01.03 Market Estimation Caveats; 4.2 Base Year; 4.3 Scope Of The Study; 4.03.01 Market Segmentation By Component; 4.03.02 Market Segmentation By Application; 4.03.03 Market Segmentation By Technology; 4.03.04 Market Segmentation By End-User; 4.03.05 Market Segmentation By Geography
5 Report Assumptions & Caveats: 5.1 Key Caveats; 5.2 Currency Conversion; 5.3 Market Derivation
6 Market At A Glance
7 Introduction: 7.1 Healthcare Artificial Intelligence (AI)
8 Market Opportunities & Trends: 8.1 Rising Investments In Advanced Drug Discovery & Development Processes; 8.2 Mergers, Acquisitions, & Collaborations With Life Science & Medical Device Companies; 8.3 Influx/Emergence Of Many Startups In The Healthcare AI Industry
9 Market Growth Enablers: 9.1 Increase In Patient Volume & Complexities Associated With Data; 9.2 Shrinking Operational Workforce In Healthcare Facilities; 9.3 Technological Advancements & Innovations In AI; 9.4 Growing Need To Reduce Healthcare Costs Using It & AI Technologies
10 Market Restraints: 10.1 High Installation & Implementation Cost Of AI & Related Platforms; 10.2 Lack Of Skilled AI Workforce & Resistance Among Healthcare Professionals; 10.3 Stringent & Ambiguous Regulations For Healthcare Software & AI Technologies; 10.4 Absence Of Interoperability Among Commercially Available Ai Solutions Coupled With Data Privacy Issues
11 Market Landscape: 11.1 Market Overview; 11.2 Market Size & Forecast; 11.3 Five Forces Analysis; 11.03.01 Threat Of New Entrants; 11.03.02 Bargaining Power Of Suppliers; 11.03.03 Bargaining Power Of Buyers; 11.03.04 Threat Of Substitutes; 11.03.05 Competitive Rivalry
12 Component: 12.1 Market Snapshot & Growth Engine; 12.2 Market Overview; 12.3 Hardware; 12.03.01 Market Overview; 12.03.02 Market Size & Forecast; 12.03.03 Hardware: Geography Segmentation; 12.4 Software & Services; 12.04.01 Market Overview; 12.04.02 Market Size & Forecast; 12.04.03 Software & Services: Geography Segmentation
13 Application: 13.1 Market Snapshot & Growth Engine; 13.2 Market Overview; 13.3 Hospital Workflow Management; 13.03.01 Market Overview; 13.03.02 Market Size & Forecast; 13.03.03 Hospital Workflow Management: Geography Segmentation; 13.4 Medical Imaging & Diagnosis; 13.04.01 Market Overview; 13.04.02 Market Size & Forecast; 13.04.03 Medical Imaging & Diagnosis: Geography Segmentation; 13.5 Drug Discovery & Precision Medicine; 13.05.01 Market Overview; 13.05.02 Market Size & Forecast; 13.05.03 Drug Discovery & Precision Medicine: Geography Segmentation; 13.6 Patient Management; 13.06.01 Market Overview; 13.06.02 Market Size & Forecast; 13.06.03 Patient Management: Geography Segmentation
14 Technology: 14.1 Market Snapshot & Growth Engine; 14.2 Market Overview; 14.3 Machine Learning; 14.03.01 Market Overview; 14.03.02 Market Size & Forecast; 14.03.03 Machine Learning: Geography; 14.4 Querying Method; 14.04.01 Market Overview; 14.04.02 Market Size & Forecast; 14.04.03 Querying Method: Geography Segmentation; 14.5 Natural Language Processing; 14.05.01 Market Overview; 14.05.02 Market Size & Forecast; 14.05.03 Natural Language Processing: Geography Segmentation; 14.6 Other Technology; 14.06.01 Market Overview; 14.06.02 Market Size & Forecast; 14.06.03 Other Technology: Geography Segmentation
15 End-User: 15.1 Market Snapshot & Growth Engine; 15.2 Market Overview; 15.3 Healthcare Providers; 15.03.01 Market Overview; 15.03.02 Market Size & Forecast; 15.03.03 Healthcare Providers: Geography Segmentation; 15.4 Pharma-Biotech & Medical Device Companies; 15.04.01 Market Overview; 15.04.02 Market Size & Forecast; 15.04.03 Pharma-Biotech & Medical Device Companies: Geography Segmentation; 15.5 Payers; 15.05.01 Market Overview; 15.05.02 Market Size & Forecast; 15.05.03 Payers: Geography Segmentation; 15.6 Others; 15.06.01 Market Overview; 15.06.02 Market Size & Forecast; 15.06.03 Other End User: Market By Geography
16 Geography: 16.1 Market Snapshot & Growth Engine; 16.2 Geographic Overview
17 North America: 17.1 Market Overview; 17.2 Market Size & Forecast; 17.02.01 North America: Component Segmentation; 17.02.02 North America: Application Segmentation; 17.02.03 North America: Technology Segmentation; 17.02.04 North America: End-User Segmentation; 17.3 Key Countries; 17.03.01 Us: Market Size & Forecast; 17.03.02 Canada: Market Size & Forecast
18 Europe: 18.1 Market Overview; 18.2 Market Size & Forecast; 18.02.01 Europe: Component Segmentation; 18.02.02 Europe: Application Segmentation; 18.02.03 Europe: Technology Segmentation; 18.02.04 Europe: End-User Segment; 18.3 Key Countries; 18.03.01 Germany: Market Size & Forecast; 18.03.02 UK: Market Size & Forecast; 18.03.03 France: Market Size & Forecast; 18.03.04 Italy: Market Size & Forecast; 18.03.05 Spain: Market Size & Forecast; 18.03.06 Nordics: Market Size & Forecast
19 APAC: 19.1 Market Overview; 19.2 Market Size & Forecast; 19.02.01 APAC: Component Segmentation; 19.02.02 APAC: Application Segmentation; 19.02.03 APAC: Technology Segmentation; 19.02.04 APAC: End-User Segmentation; 19.3 Key Countries; 19.03.01 China: Market Size & Forecast; 19.03.02 India: Market Size & Forecast; 19.03.03 Japan: Market Size & Forecast; 19.03.04 Australia: Market Size & Forecast; 19.03.05 South Korea: Market Size & Forecast
20 Latin America: 20.1 Market Overview; 20.2 Market Size & Forecast; 20.02.01 Latin America: Component Segmentation; 20.02.02 Latin America: Application Segmentation; 20.02.03 Latin America: Technology Segmentation; 20.02.04 Latin America: End-User Segmentation; 20.3 Key Countries; 20.03.01 Brazil: Market Size & Forecast; 20.03.02 Mexico: Market Size & Forecast; 20.03.03 Argentina: Market Size & Forecast
21 Middle East & Africa: 21.1 Market Overview; 21.2 Market Size & Forecast; 21.02.01 Middle East & Africa: Component Segmentation; 21.02.02 Middle East & Africa: Application Segmentation; 21.02.03 Middle East & Africa: Technology Segmentation; 21.02.04 Middle East & Africa: End-User Segmentation; 21.3 Key Countries; 21.03.01 Turkey: Market Size & Forecast; 21.03.02 Saudi Arabia: Market Size & Forecast; 21.03.03 South Africa: Market Size & Forecast; 21.03.04 UAE: Market Size & Forecast
22 Competitive Landscape: 22.1 Competition Overview; 22.2 Market Share Analysis; 22.02.01 Google; 22.02.02 IBM; 22.02.03 Intel; 22.02.04 Medtronic; 22.02.05 Microsoft; 22.02.06 NVIDIA; 22.02.07 Siemens Healthineers
23 Key Company Profiles: 23.1 GOOGLE; 23.01.01 Business Overview; 23.01.02 Product Offerings; 23.01.03 Key Strategies; 23.01.04 Key Strengths; 23.01.05 Key Opportunities; 23.2 INTERNATIONAL BUSINESS MACHINES (IBM); 23.02.01 Business Overview; 23.02.02 Product Offerings; 23.02.03 Key Strategies; 23.02.04 Key Strengths; 23.02.05 Key Opportunities; 23.3 INTEL CORPORATION; 23.03.01 Business Overview; 23.03.02 Product Offerings; 23.03.03 Key Strategies; 23.03.04 Key Strengths; 23.03.05 Key Opportunities; 23.4 MEDTRONIC; 23.04.01 Business Overview; 23.04.02 Product Offerings; 23.04.03 Key Strategies; 23.04.04 Key Strengths; 23.04.05 Key Opportunities; 23.5 MICROSOFT CORPORATION; 23.05.01 Business Overview; 23.05.02 Product Offerings; 23.05.03 Key Strategies; 23.05.04 Key Strengths; 23.05.05 Key Opportunities; 23.6 NVIDIA CORPORATION; 23.06.01 Business Overview; 23.06.02 Product Offerings; 23.06.03 Key Strategies; 23.06.04 Key Strengths; 23.06.05 Key Opportunities; 23.7 SIEMENS HEALTHINEERS; 23.07.01 Business Overview; 23.07.02 Product Offerings; 23.07.03 Key Strategies; 23.07.04 Key Strengths; 23.07.05 Key Opportunities
24 Other Prominent Vendors: 24.1 ARTERYS; 24.01.01 Business Overview; 24.01.02 Product Offerings; 24.2 CAPTION HEALTH; 24.02.01 Business Overview; 24.02.02 Product Offerings; 24.3 ENLITIC; 24.03.01 Business Overview; 24.03.02 Product Offerings; 24.4 CATALIA HEALTH; 24.04.01 Business Overview; 24.04.02 Product Offerings; 24.5 GENERAL VISION; 24.05.01 Business Overview; 24.05.02 Product Offerings; 24.6 PHILIPS; 24.06.01 Business Overview; 24.06.02 Product Offerings; 24.7 STRYKER; 24.07.01 Business Overview; 24.07.02 Product Offerings; 24.8 SHIMADZU RECURSION PHARMACEUTICALS; 24.08.01 Business Overview; 24.08.02 Product Offerings; 24.9 GE HEALTHCARE; 24.09.01 Business Overview; 24.09.02 Product Offerings; 24.10 REMEDY MEDICAL; 24.10.01 Business Overview; 24.10.02 Product Offerings; 24.11 SUBTLE MEDICAL; 24.11.01 Business Overview; 24.11.02 Product Offerings; 24.12 NETBASE QUID; 24.12.01 Business Overview; 24.12.02 Product Offerings; 24.13 BIOSYMETRICS; 24.13.01 Business Overview; 24.13.02 Product Offerings; 24.14 SENSELY; 24.14.01 Business Overview; 24.14.02 Product Offerings; 24.15 INFORMAI; 24.15.01 Business Overview; 24.15.02 Product Offerings; 24.16 BIOCLINICA; 24.16.01 Business Overview; 24.16.02 Product Offerings; 24.17 OWKIN; 24.17.01 Business Overview; 24.17.02 Product Offerings; 24.18 BINAH.AI; 24.18.01 Business Overview; 24.18.02 Product Offerings; 24.19 ONCORA MEDICAL; 24.19.01 Business Overview; 24.19.02 Product Offerings; 24.20 QURE.AI TECHNOLOGIES; 24.20.01 Business Overview; 24.20.02 Product Offerings; 24.21 LUNIT; 24.21.01 Business Overview; 24.21.02 Product Offerings; 24.22 CARESYNTAX; 24.22.01 Business Overview; 24.22.02 Product Offerings; 24.23 ANJU SOFTWARE; 24.23.01 Business Overview; 24.23.02 Product Offerings; 24.24 IMAGIA CYBERNETICS; 24.24.01 Business Overview; 24.24.02 Product Offerings; 24.25 DEEP GENOMICS; 24.25.01 Business Overview; 24.25.02 Product Offerings; 24.26 WELLTOK INC.; 24.26.01 Business Overview; 24.26.02 Product Offerings; 24.27 MDLIVE; 24.27.01 Business Overview; 24.27.02 Product Offerings; 24.28 MAXQ AI; 24.28.01 Business Overview; 24.28.02 Product Offerings; 24.29 QVENTUS; 24.29.01 Business Overview; 24.29.02 Product Offerings; 24.30 WORKFUSION; 24.30.01 Business Overview; 24.30.02 Product Offerings
25 Report Summary: 25.1 Key Takeaways; 25.2 Strategic Recommendations
26 Quantitative Summary: 26.1 Market By Component; 26.01.01 North America: Component Segmentation; 26.01.02 Europe: Component Segmentation; 26.01.03 Apac: Component Segmentation; 26.01.04 Latin America: Component Segmentation; 26.01.05 Middle East & Africa: Component Segmentation; 26.2 Market By Application; 26.02.01 North America: Application Segmentation; 26.02.02 Europe: Application Segmentation; 26.02.03 Apac: Application Segmentation; 26.02.04 Latin America: Application Segmentation; 26.02.05 Middle East & Africa: Application Segmentation; 26.3 Market By Technology; 26.03.01 North America: Technology Segmentation; 26.03.02 Europe: Technology Segmentation; 26.03.03 Apac: Technology Segmentation; 26.03.04 Latin America: Technology Segmentation; 26.03.05 Middle East & Africa: Technology Segmentation; 26.4 Market By End-User; 26.04.01 North America: End-User Segmentation; 26.04.02 Europe: End-User Segmentation; 26.04.03 Apac: End-User Segmentation; 26.04.04 Latin America: End-User Segmentation; 26.04.05 Middle East & Africa: End-User Segmentation; 26.5 Market By Geography; 26.05.01 Hardware: Geography Segmentation; 26.05.02 Software & Services: Geography Segmentation; 26.05.03 Hospital Workflow Management: Geography Segmentation; 26.05.04 Medical Imaging & Diagnosis: Geography Segmentation; 26.05.05 Drug Discovery & Precision Medicine: Geography Segmentation; 26.05.06 Patient Management: Geography Segmentation; 26.05.07 Machine Learning: Geography Segmentation; 26.05.08 Querying Method: Geography Segmentation; 26.05.09 Natural Language Processing: Geography Segmentation; 26.05.10 Other Technologies: Geography Segmentation; 26.05.11 Healthcare Providers: Geography Segmentation; 26.05.12 Pharma-Biotech & Medical Device Companies: Geography Segmentation; 26.05.13 Payers: Geography Segmentation; 26.05.14 Other End-Users: Geography Segmentation
27 Appendix: 27.1 Abbreviations